Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pseudobulbar Affect”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Large-scale testing (Phase 3)Study completedNCT00021697
What this trial is testing

Safety/Efficacy of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Crying & Laughing) in Patients With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Avanir Pharmaceuticals 100
Large-scale testing (Phase 3)Study completedNCT00573443
What this trial is testing

Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS

Who this might be right for
Pseudobulbar Affect (PBA)
Avanir Pharmaceuticals 326
Not applicableLooking for participantsNCT06396260
What this trial is testing

Structural and Functional Networks in ALS: An Insight Into Pseudobulbar Affect

Who this might be right for
Amyotrophic Lateral SclerosisPseudobulbar Affect
Aalborg University Hospital 50
Not applicableStudy completedNCT01366027
What this trial is testing

PRISM Registry: Pseudobulbar Affect Registry Series

Who this might be right for
Alzheimer's DiseaseAmyotrophic Lateral Sclerosis (ALS)Multiple Sclerosis (MS)+3 more
Avanir Pharmaceuticals 5,290
Post-approval studies (Phase 4)Ended earlyNCT01832350
What this trial is testing

Nuedexta in the Treatment of Pseudobulbar Affect in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's DiseasePseudobulbar Affect (PBA)
St. Joseph's Hospital and Medical Center, Phoenix 34
Post-approval studies (Phase 4)Study completedNCT01799941
What this trial is testing

Safety, Tolerability and Effectiveness of Nuedexta in the Treatment of Pseudobulbar Affect (PBA)

Who this might be right for
Pseudobulbar Affect (PBA)StrokeDementia+1 more
Avanir Pharmaceuticals 367
Large-scale testing (Phase 3)Study completedNCT00056524
What this trial is testing

Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)

Who this might be right for
Alzheimer's DiseaseStrokeParkinson's Disease+1 more
Avanir Pharmaceuticals 600
Not applicableNot Yet RecruitingNCT06457126
What this trial is testing

Piloting the Attention Training Technique for Post-Stroke Emotionalism

Who this might be right for
StrokeEmotionalityPseudobulbar Affect+2 more
University of Manchester 14
Post-approval studies (Phase 4)Ended earlyNCT02496039
What this trial is testing

Effectiveness, Safety, and Health-Related Outcomes of NUEDEXTA® in Nursing Home Patients With Pseudobulbar Affect (PBA)

Who this might be right for
Pseudobulbar Affect (Involuntary Laughing and/or Crying)
Avanir Pharmaceuticals 5
Large-scale testing (Phase 3)Study completedNCT00050232
What this trial is testing

Safety and Efficacy of AVP-923 for Pseudobulbar Affect in Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis
Avanir Pharmaceuticals 96